Roundtable Discussion: Promise, Perils and Progress when Publishing in Biotech
Time: 11:30 am
day: Pre-Conference Day
Details:
We have come through a major difficult period in funding for imaginative biotech, especially in the cell and gene therapy area.
Although academics have been told to ‘publish or perish’, this is less clear in biotechnology.
• De-risking investment by having vetted science peer reviewed and published
• Formalizing reporting activities with suitable scientific controls allows the knowns and the unknowns to come to life
• Promoting a work culture that values the individual and groups and their contributions, realized in publication
